medigraphic.com
ISSN 0035-0052 (Print)

2004, Number 5

<< Back Next >>

Rev Mex Pediatr 2004; 71 (5)

Pneumonitis for Pneumocystis carinii, clinical and pathological research. A case report

Carrada BT

Language: Spanish
References: 49
Page: 229-236
PDF size: 197.93 Kb.


ABSTRACT

The incidence of Pneumocystis carinii pneumonia in children with HIV-AIDS has motivated the clinical d laboratory investigation about this microorganism and the diagnosis, treatment and prevention of it’s associated disease. The case of a preeschool child with this illness it is presented; the clinical-pathological investigation done for the identification the P. Carinii; as well the histopathological particularities of the damage tissues and the ultrastructural issues of this microorganism. The available laboratory procedures for their diagnosis, related to the development of fluorescent monoclonal antibodies and the polymerase chain reaction, are revised. Mention is also done to the chemotherapy with trimethoprim-sulfamethoxazole (TMP-SMZ) and other therapeutic alternatives and in regard to measures of prevention.


REFERENCES

  1. Walzer PD. Pneumocystis carinii. In: Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 5a Ed. Filadelfia: Churchill-Livingstone, 2000: 2781-95.

  2. Stringer JR, Walzer PD. Molecular biology and epidemiology of Pneumocystis carinii infection in AIDS. AIDS 1996; 10: 561-71.

  3. Tasci S, Ewing S, Burghard A, Lüderitz B. Pneumocystis carinii pneumonia. Lancet 2003; 362: 124-5.

  4. Arean VM. Pulmonary Pneumocystosis. In: Marcial-Rojas RA. Pathology of Protozoal and Helminthic Diseases. Baltimore: Williams & Wilkins, 1971.

  5. Campbell WG. Ultrastructure of Pneumocystis in human lung. Arch Pathol 1972; 93: 312-21.

  6. Morris A, Ben Beard C, Huang L. Update on the epidemiology and transmission of Pneumocystis carinii. Microb Infect 2002; 4: 95-103.

  7. Ruskin J, Remington JS. Neumocistosis. En: Hoeprich PD. Tratado de Enfermedades Infecciosas. Barcelona: Salvat 1982: 410-15.

  8. Walzer PD, Schultz MG, Western K, Robbins JB. Pneumocystis carinii pneumonia and primary immune deficiency disease of infancy and childhood. J Pediatr 1973; 82: 416-22.

  9. Hughes WT. Pneumocystis carinii Pneumonia. In: Pediatrics AIDS the Challenge of HIV infection in Infants, Children and Adolescents. Baltimore: Williams & Willkins, 1994: 405-18.

  10. Ognibene FP, Gil VJ, Pizzo PA. Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppresed pediatric patients. J Pediatr 1989; 115: 430-3.

  11. Frenkel JK. Pneumocystosis. In: Binford ChH, Connor D. Pathology of Tropical and Extraordinary Diseases. Vol I. Washington DC: Armed Forces Inst Pathology 1976: 303-7.

  12. Cregan P, Yamamoto A, Lum A. Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 1990; 28: 2432-6.

  13. Aslanzadeh J, Stelmach PS. Detection of Pneumocystis carinii with direct fluorescence antibody and calcofluor white stain. Infection 1996; 24: 248-50.

  14. Kitada K, Oka S, Kimwa S, Shimada K, Serikawa T. Detection of Pneumocystis carinii sequence by polymerase chain reaction: Animal models and clinical applications to noninvasive specimens. J Clin Microbiol 1992; 29: 1985-90.

  15. Kasolo F, Lshimpi K, Chintu Ch, Mwaba P, Mudenda V, Maswabu D et al. Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory illnesses. J Pediatrics 2002; 140: 367-9.

  16. Ridaura-Sanz C. Infección por Pneumocystis carinii en niños. Características anatomoclínicas de 23 casos de autopsia. Patología 1995; 33: S7-S12.

  17. Bye MR, Bernstein L, Shah K, Ellawie M, Rubinstein A. Diagnostic bronchoalveolar lavage in children with AIDS. Pediatr Pulmonol 1987; 3: 425-8.

  18. Kovaks JA, Gill VJ, Masur H. New Insights Into Transmission, Diagnosis and Drug Treatment of Pneumocystis carinii Pneumonia. JAMA 2001; 286: 2450-60.

  19. Cushion MT. Transmission and epidemiology. In: Walzer PD ed. Pneumocystis carinii Pneumonia New York, NY: Marcel-Dekker, 1994: 122-39.

  20. Jesserum J, Angeles-Angeles A, Gasman N. Comparative demographic and autopsy findings in the acquired immune deficiency syndrome in two Mexican populations. J Acquir Immune Defic Syndrome 1990; 3: 579-83.

  21. Hughes WT, Price RA, Kim HK, Coburn TP, Grisby D, Feldman S. Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 1973; 82: 404-415.

  22. Vanek J, Jirovek O. Parasitare Pneumonie “Interstitielle” Plasma Zellen Pneumoniae del Fruhgeborenen, verursacht durch Pneumocystis carinii. Zentral bl Bakteriol (Orig A). 1952; 158: 120-127.

  23. Gajdusek DC. Pneumocystis carinii- etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 1957; 19: 543-65.

  24. Hughes WT. Pneumocystis carinii pneumonitis. Boca Raton, Fl: CRC Press, 1987.

  25. Rogers MA. AIDS in children: a review of the clinical, epidemiological and public health aspects. Pediatr Infect Dis 1985; 4: 230-36.

  26. Kaplan JE, Hanson D, Dworkin MS. Epidemiology of human immunodeficiency virus –associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30(Suppl 1): S5-S14.

  27. Pifer LL, Hughes WT, Stagno S, Woods D. Pneumocystis carinii infection: Evidence of high prevalence in normal and immunosuppressed children. Pediatrics 1978; 61: 35-40.

  28. Meuwissen JHE, Tauber Th, Leeuwenberg ADEM, Beckers PJA, Sieben M. Parasitology and serologic observations of infection with Pneumocystis carinii in humans. J Infect Dis 1977; 136: 43-48.

  29. Figueroa-Medrano LP, Xochihua-Díaz L, Figueroa-Damián R. Características clínicas y epidemiológicas de pacientes pediátricos con infección VIH/SIDA: informe de 124 pacientes. Bol Med Hosp. Infant Mex 2001; 58; 771-9.

  30. Maldonado JS, Gutierrez-Rojas A, Conde-Mercado JM, Estrada-Aguilera A. La evolución de pacientes con SIDA en el Hospital Juárez de México. Med Inter Mex 2000; 16: 111-6.

  31. del Río-Chiribonga C, Tellez-Gómez I, Orzechowski-Rallo A, Alanis-Ortega A. The Spectrum of HIV Infection in Patients Seen at a Private Hospital in Mexico City: 115 Patients Seen from 1984 to 1999. Arch Med Res 1996; 27: 201-4.

  32. Gómez-Campos G, Villareal-Urenda C, Robles-Romo M, Cano-Domínguez C. Hallazgos histopatológicos en 102 autopsias de pacientes con Síndrome de Inmunodeficiencia Adquirida. Rev Med IMSS (Mex) 1992; 30: 171-6.

  33. Centers for Disease Control and Prevention. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1989; 38: 1-9.

  34. Volpe F, Ballantine SP, Delves CI. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii encodes dihydroneopterin aldolase, hidroxymethsintethase. Eur J Biochem 1993; 216: 449-58.

  35. Centers for Disease Control and Prevention, 1999. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1999; 48: 1-66.

  36. Para MF, Finkelstein D, Becker S. Reduced toxicity with gradual initiation of trimethoprim for Pneumocystis carinii pneumonia: AIDS clinical trial group 268. J Acquir Immune Defic Syndr Hum Retrovirol 2000; 24: 337-43.

  37. Ioannidis JP, Cappelleni JC, Skolnik PR. A metanalysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med 1996; 156: 177-88.

  38. Looareesuwan S, Viravan C, Webster HK. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 1996; 54: 62-6.

  39. Walker DJ, Wakenfield AE, Dohn MN. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J Infect Dis 1998; 178: 1767-1775.

  40. Bozzette SA, Sattler FR, Chiu J. A controlled field trial adjunctive treatment with corticoesteroides for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1451-7.

  41. Simonds RJ, Hughes WT, Feinberg J, Navin TR. Preventing Pneumocystis carinii Pneumonia in Persons Infected with Human Immunodeficiency Virus. Clin Infect Dis 1995; 21(Suppl 1): S44-S48.

  42. López-Bernaldo de Quiroz JC, Miro JM, Peña JM, Podzamczer D, Alberdi JC, Martinez E et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV-infection. N Engl J Med 2001; 344: 159-67.

  43. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be member of the fungi. Nature 1988; 334: 519-29.

  44. Hughes TT. Pneumocystis carinii: Taxing the taxonomy. Eur J Epidemiol 1989; 17: 5349-58.

  45. Fishmand JA. Pneumocystis carinii pneumonia. In: Fishman AP ed. Update: Pulmonary diseases and disorders. New York: McGraw-Hill, 1992. 263-86.

  46. Fishman JA, Lee MJ, Mattia AR. Case 3-1995, Records of the Massachussets General Hospital. N Engl J Med 1995; 332: 249-57.

  47. Telzak EE, Cote RJ, Gold JWM, Campbell SW, Armstrong D. Extrapulmonary Pneumocystis carinii infection. Rev Infect Dis 1990; 12: 380-386.

  48. Afessa B, Green W, Chiao J. Pulmonary complications of HIV-infections: autopsy findings. Chest 1998; 113: 1225-29.

  49. Ruviglioni MC. Extrapulmonary pneumocystosis. The first 50 cases. Rev Infect Dis 1990; 12: 1127-38.




2020     |     www.medigraphic.com